| 词条 | Exbivirumab |
| 释义 |
| Verifiedfields = changed | verifiedrevid = 457121609 | type = mab | mab_type = mab | source = u | target = hepatitis B surface antigen | tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | CAS_number_Ref = {{cascite|changed|??}} | CAS_number = 569658-80-6 | ATC_prefix = none | ATC_suffix = | PubChem = | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = none | C=6416 | H=9924 | N=1732 | O=1982 | S=44 | molecular_weight = }}Exbivirumab is a human monoclonal antibody[1] developed for the treatment of hepatitis B infections.[2] References1. ^WHO Drug Information {{Monoclonals for infectious disease and toxins}}{{antiinfective-drug-stub}}{{monoclonal-antibody-stub}}2. ^{{cite journal|last=Shouval|first=D|year=2006|title=Anti-Viral Effects, Pharmacokinetics and Safety of Two Human Monoclonal Anti-Hbs (Libivirumab/Exbivirumab) Versus Hepatitis B Immune Globulin (Hbig) in Hepatitis B Virus (Hbv) in Liver Transplant (Lt) Recipients|journal=Hepatology|volume=44|issue=4|doi=10.1002/hep.21395 |pmid=17001593|pages=188A–700A [196A]|display-authors=etal}} 2 : Monoclonal antibodies|Experimental drugs |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。